Bluebird Bio | BLUE - القيمة السوقية



القيمة السوقية تغيير تاريخ
Agios Pharmaceuticals USD 1.61B 598M 2026-11
Alnylam Pharmaceuticals USD 33.02B 7.17B 2026-09
Amgen USD 247.94B 20.06B 2026-11
Arrowhead Research USD 11.5B 2.72B 2026-06
Biogen USD 33.38B 1.48B 2026-09
BioMarin Pharmaceutical USD 10.95B 667M 2026-11
Gilead Sciences USD 184.82B 27.96B 2026-09
Incyte USD 24.6B 1.95B 2026-09
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Moderna USD 99.14B 22.26B 2026-11
Nektar Therapeutics USD 2.12B 1.26B 2026-03
Novartis USD 292.09B 51.5B 2026-09
Pfizer USD 169.88B 6.47B 2026-11
Sarepta Therapeutics USD 1.65B 276M 2026-11
Tectonic Therapeutic USD 649M 69M 2026-06
Ultragenyx Pharmaceutical USD 1.37B 108M 2026-11
Vertex Pharmaceuticals USD 142.88B 10.37B 2026-11